J.J. Kiladjian

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

J.J. Kiladjian

Aug 23, 2024, 14:01 | Insight

J.J. Kiladjian: First European Use of Anti-Mutant CALR Bispecific Antibody for Myelofibrosis

J.J. Kiladjian, Professor of Clinical Pharmacology at Paris Diderot University, shared on X: "Today at…

Jun 16, 2024, 12:58 | Insight

Prithviraj Bose: Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS

Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X: "Encouraging to…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023